Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Douglas B. Fox(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), Genevieve M. Boland(Harvard University), Joanna Vuille(Harvard University), Xin Hong(Southern University of Science and Technology), Thomas J. LaSalle(Harvard University), Nir Hacohen(Cambridge Hospital), Debattama R. Sen(Harvard University), Hunter C. Russell(Harvard University), Ben S. Wittner(Broad Institute), Shyamala Maheswaran(Massachusetts General Hospital), Mehmet Toner(Center for Cancer Research), Hongshan Guo(Howard Hughes Medical Institute), Nicolas Poux(Broad Institute), Richard Y. Ebright(Harvard University), Ryan J. Sullivan(Dana-Farber Cancer Institute)
Cited by 17
Related Papers
Full-length transcriptome assembly from RNA-Seq data without a reference genome
|Nature Biotechnology|2011|22.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k